Table 5.
Beta coefficients for mean percentages of patients with T2D with an HbA1c result recorded
Beta coefficient | P value | |
Model 1* | ||
Sex | ||
Female | Reference | |
Male | 2.5 (1.7, 3.4) | <0.001 |
Model 2* | ||
Obesity | ||
BMI<30 | Reference | |
BMI≥30 | 9.6 (8.8, 10.4) | <0.001 |
Model 3* | ||
Age (years) | ||
18–54 | Reference | |
55–74 | 7.5 (6.6, 8.5) | <0.001 |
75+ | 7.1 (6.2, 7.9) | <0.001 |
Model 4* | ||
General practice density (for each additional general practice per 10 000 persons) | 8.4 (4.9, 11.8) | <0.001 |
Model 5* | ||
COVID-19 | ||
No lockdown | Reference | |
COVID-19 lockdown | 0.8 (0.3, 1.3) | 0.003 |
Beta coefficients for mean percentages of active patients with T2D in their general practice record from September 2020 to June 2022. Data are beta coefficient (95% CI) for mean percentage of patients with an HbA1c test result in the past 15 months (see table 3) after correction for any linear changes over time.
*Corrected for time trend.
BMI, body mass index; T2D, type 2 diabetes.